Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,949 | -1,240 | -623 | -1,598 | -1,250 |
| Depreciation Amortization | 125 | 82 | 40 | 153 | 110 |
| Accounts receivable | -162 | -368 | -113 | 148 | 151 |
| Accounts payable and accrued liabilities | -1,228 | -113 | -318 | 204 | -258 |
| Other Working Capital | -1,139 | -423 | -311 | 115 | -323 |
| Other Operating Activity | 1,552 | 500 | 500 | -1,257 | -742 |
| Operating Cash Flow | $-2,799 | $-1,562 | $-824 | $-2,234 | $-2,313 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -31 | -9 | -227 | -223 |
| Purchase Of Investment | -9 | N/A | N/A | -493 | -486 |
| Sale Of Investment | 1,021 | N/A | N/A | 1,069 | 495 |
| Other Investing Activity | -25 | -14 | -7 | 69 | 78 |
| Investing Cash Flow | $951 | $-44 | $-16 | $418 | $-136 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 32 | -2 | -1 | 145 | 146 |
| Financing Cash Flow | $32 | $-2 | $-1 | $145 | $146 |
| Exchange Rate Effect | 287 | 258 | 43 | 40 | 450 |
| Beginning Cash Position | 2,887 | 2,887 | 2,887 | 4,518 | 4,518 |
| End Cash Position | 1,357 | 1,537 | 2,089 | 2,887 | 2,665 |
| Net Cash Flow | $-1,530 | $-1,350 | $-798 | $-1,631 | $-1,852 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,799 | -1,562 | -824 | -2,234 | -2,313 |
| Capital Expenditure | -36 | -31 | -9 | -227 | -223 |
| Free Cash Flow | -2,835 | -1,593 | -833 | -2,461 | -2,536 |